Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd.
As of 18 November 2026, for the company name Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. as recorded, the chemical-drug catalogue lists 12 active records with this name as holder; 35 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
19 acceptance records as first applicant, grouped into 14 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Metoprolol Tartrate Injection 1 records · Latest accepted 2026/08/18
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601569 | Supplement | 2026/08/18 | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | CDE ↗ |
Bromhexine Hydrochloride Injection 1 records · Latest accepted 2026/04/17
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600777 | Supplement | 2026/04/17 | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | CDE ↗ |
Metaraminol Tartrate Injection 1 records · Latest accepted 2025/04/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501612 | Generic | 2025/04/29 | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | CDE ↗ |
Dobutamine Hydrochloride Injection 1 records · Latest accepted 2025/04/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501574 | Generic | 2025/04/25 | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | CDE ↗ |
Chlorphenamine Maleate Injection 1 records · Latest accepted 2025/01/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2550033 | Supplement | 2025/01/09 | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | CDE ↗ |
Pentoxifylline Injection 1 records · Latest accepted 2024/11/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403851 | Generic | 2024/11/11 | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | CDE ↗ |
Ambroxol Hydrochloride Injection 1 records · Latest accepted 2024/07/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402090 | Generic | 2024/07/10 | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | CDE ↗ |
Sulpiride Injection 4 records · Latest accepted 2024/06/05
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2400757 | Supplement | 2024/06/05 | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2400756 | Supplement | 2024/06/05 | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2400464 | Supplement | 2024/04/02 | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2400463 | Supplement | 2024/04/02 | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | CDE ↗ |
Dopamine Hydrochloride Injection 1 records · Latest accepted 2024/03/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400892 | Generic | 2024/03/22 | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | CDE ↗ |
Diprophylline Injection 1 records · Latest accepted 2024/01/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450014 | Supplement | 2024/01/09 | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | CDE ↗ |
Thioctic Acid Injection 1 records · Latest accepted 2023/04/22
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350375 | Supplement | 2023/04/22 | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | CDE ↗ |
Tranexamic Acid Injection 2 records · Latest accepted 2023/03/17
Supplement · 2
Lidocaine Hydrochloride Injection 1 records · Latest accepted 2023/02/27
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350219 | Supplement | 2023/02/27 | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | CDE ↗ |
Piracetam Injection 2 records · Latest accepted 2022/08/02
Supplement · 2
Changes in the last 90 days
0 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
- No matching records were found in the currently loaded source data; coverage dates are listed below.
Under review
2 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Metaraminol Tartrate Injection | CYHS2501612 | Generic | 2025/04/29 | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | CDE ↗ |
| Dobutamine Hydrochloride Injection | CYHS2501574 | Generic | 2025/04/25 | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | CDE ↗ |
Catalogue holder records
12 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Pentoxifylline Injection | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | 国药准字H20264612 | 2026/06/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Chlorphenamine Maleate Injection | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | 国药准字H41022116 | 2025/11/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ambroxol Hydrochloride Injection | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | 国药准字H20255879 | 2025/11/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dopamine Hydrochloride Injection | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | 国药准字H20255823 | 2025/11/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Diprophylline Injection | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | 国药准字H20258029 | 2025/03/13 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Diprophylline Injection | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | 国药准字H20258029 | 2025/03/13 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Thioctic Acid Injection | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | 国药准字H20247164 | 2024/07/12 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Tranexamic Acid Injection | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | 国药准字H20247042 | 2024/03/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Tranexamic Acid Injection | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | 国药准字H20184047 | 2024/03/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Lidocaine Hydrochloride Injection | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | 国药准字H20173160 | 2024/01/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Piracetam Injection | Shanghai Xian Dai Ha Sen (Shang Qiu) Pharma Co., Ltd. romanized | Shanghai Xian Dai Ha Sen (Shang Qiu) Pharma Co., Ltd. romanized | 国药准字H20067957 | 2023/06/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Piracetam Injection | Shanghai Xian Dai Ha Sen (Shang Qiu) Pharma Co., Ltd. romanized | Shanghai Xian Dai Ha Sen (Shang Qiu) Pharma Co., Ltd. romanized | 国药准字H20237071 | 2023/06/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
35 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 盐酸多巴酚丁胺 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20240001000 | A | 2026/03/25 | CDE ↗ |
| 重酒石酸间羟胺 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20240000275 | A | 2025/11/11 | CDE ↗ |
| 重酒石酸去甲肾上腺素 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20230000575 | A | 2025/02/07 | CDE ↗ |
| 肾上腺素 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20230000531 | A | 2025/01/06 | CDE ↗ |
| 盐酸多巴胺 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20230000334 | A | 2024/12/03 | CDE ↗ |
| 维生素K1 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20220001273 | A | 2025/07/15 | CDE ↗ |
| 盐酸利多卡因 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20220000099 | A | 2024/03/14 | CDE ↗ |
| 盐酸雷尼替丁 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20180001798 | A | 2024/04/19 | CDE ↗ |
| 甘草酸二铵 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20190007909 | A | 2025/07/04 | CDE ↗ |
| 马来酸依那普利 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20190007752 | A | 2025/07/04 | CDE ↗ |
| 格列齐特 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20190007750 | A | — | CDE ↗ |
| 曲克芦丁 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20190007721 | A | 2025/03/12 | CDE ↗ |
| 桂利嗪 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20190007720 | A | 2025/03/12 | CDE ↗ |
| 盐酸伊曲康唑 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20190006636 | A | — | CDE ↗ |
| 西咪替丁 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20190006611 | A | — | CDE ↗ |
| 马来酸氯苯那敏 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20190006609 | A | — | CDE ↗ |
| 亚硫酸氢钠甲萘醌 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20190003483 | A | 2025/07/04 | CDE ↗ |
| 二羟丙茶碱 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20190003428 | A | 2025/07/04 | CDE ↗ |
| 消旋山莨菪碱 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20190003425 | A | 2025/07/04 | CDE ↗ |
| 盐酸萘甲唑啉 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20190003423 | A | 2025/07/04 | CDE ↗ |
| 罗红霉素 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20190001892 | A | 2025/03/12 | CDE ↗ |
| 吡拉西坦 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20190001696 | A | 2025/03/12 | CDE ↗ |
| 卡马西平 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20190001695 | A | 2025/03/12 | CDE ↗ |
| 枸橼酸铋钾 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20190001694 | A | 2025/03/12 | CDE ↗ |
| 硫酸胍生 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20190001687 | A | 2025/03/12 | CDE ↗ |
| 保泰松 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20190001678 | A | 2025/03/12 | CDE ↗ |
| 氨甲环酸 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20190001677 | A | 2025/03/12 | CDE ↗ |
| 氨甲苯酸 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20170002337 | A | 2024/02/19 | CDE ↗ |
| 氨茶碱 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20170002336 | A | 2025/06/17 | CDE ↗ |
| 对乙酰氨基酚 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20170002335 | A | 2023/03/24 | CDE ↗ |
| 茶碱 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20170002044 | A | 2025/06/17 | CDE ↗ |
| 盐酸倍他司汀 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20170001176 | A | 2026/01/01 | CDE ↗ |
| 硫酸氢氯吡格雷 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20170001110 | I | — | CDE ↗ |
| 盐酸氨溴索 · No verified English name | Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | Y20170000917 | A | 2026/01/01 | CDE ↗ |
| 氨甲苯酸 · No verified English name | Shanghai Xian Dai Ha Sen (Shang Qiu) Pharma Co., Ltd. romanized | Y20170000733 | I | — | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
3 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 亚硫酸氢钠甲萘醌注射液 · No verified English name | CYHB2601897 | Supplement | 2026/10/15 | Henan He Zhi Pharmaceuticals Technology Co., Ltd. romanized; Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | CDE ↗ |
| Metoprolol Tartrate Injection | CYHS2500749 | Generic | 2025/02/15 | Bai Yun Shandong Tai Shang Qiu Pharma Co., Ltd. romanized; Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | CDE ↗ |
| Bromhexine Hydrochloride Injection | CYHS2403464 | Generic | 2024/10/15 | Bai Yun Shandong Tai Shang Qiu Pharma Co., Ltd. romanized; Shanghai Xiandai Hasen(Shangqiu)Pharmaceutical Co., Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.